BioForward Member Directory

RPT Labworks is a Contract Research Organization (CRO) that provides comprehensive early-stage development, optimization and testing services to big pharma, mid-size biotech, and startups that need access to specialized infrastructure and expertise to advance their radiopharmaceutical theranostics pipelines.

Sanofi US is a worldwide leader in research and development of pharmaceuticals, vaccines, biologicals, and consumer health products.

Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patient's daily life, wherever they live and enable them to enjoy a healthier life.

Manufactures active pharmaceutical ingredients, specifically heparin and pancreatic enzymes. Also very active in contract development and manufacturing in the biotechnology sector.

Scientific Protein Laboratories (SPL) has been a leading global supplier of high quality active pharmaceutical ingredients (APIs) for over three decades. Specializes in cGMP biopharmaceutical manufacturing and are among the largest commercial suppliers of Heparin Sodium USP, Pancreatin USP, and Pancrelipase USP. SPL serves the pharmaceutical, veterinary, and food industries globally. Our manufacturing facility is located in Waunakee, Wisconsin.

Founded in 2007, Spaulding Clinical is a full-service, state-of-the-art paperless Phase I clinical pharmacology unit. Our facility, originally a hospital, features fully integrated bedside electronic data capture and sets the standard for patient care. We specialize in IND-enabling clinical pharmacology studies, cardiovascular safety, and clinical proof of concept. We provide expertise on study design, offering in-house medical writing, clinical data management, biostatistics, project management, clinical laboratory, and PK/PD analysis.

SpayVac is a Madison, Wisconsin-based biotechnology company developing single-dose, long-lasting vaccines for animal fertility control. At the heart of its technology is a patented liposome-based delivery platform that sets SpayVac apart from conventional approaches: a single injection provides long-lasting contraceptive protection — no booster required. By offering a non-lethal, minimally invasive alternative to surgical sterilization and repeated vaccine treatments, SpayVac is redefining how agricultural producers, wildlife managers, and conservationists address the challenge of animal population control. SpayVac's lead vaccine has proven effective across a wide range of species, including feral horses, deer, seals, African elephants, and Asian elephants. The company is also developing solutions for aquaculture and companion animals.

‍

Squire Biosciences is developing a simple, scalable approach to manufacture gene therapies.

Stem Pharm synthetic biomaterials enable manufacturing of functional biological structures from stem cells for drug discovery and therapeutic applications.

A contract development and manufacturing organization (CDMO) with world-class facilities in the UK and US. Over 50 years experience in delivering small molecule services spanning pre-clinical development to full commercial cGMP manufacturing.

SU Group offers the most innovative, flexible and comprehensive Equipment Maintenance Management Program (EMMP) available today. The program converts eligible contracts to a time and material basis, contract-to-contract, or alternative solutions, while managing the vendors and assuming this financial risk. With Specialty Underwriters, customers will receive a multitude of benefits while experiencing a 10-30% discount off OEM list pricing.

TCR Biotherapeutics is a preclinical biotechnology company focused on transforming the lives of patients burdened with severe and life-threatening autoimmune diseases. We are developing a next-generation pipeline of off-the-shelf and universally compatible therapeutics derived from T Cell receptors (TCR) with the goal of treating autoimmune disease and graft-versus-host disease (GVHD). Based in Milwaukee, Wisconsin, TCR Biotherapeutics is currently conducting preclinical work ahead of first-in-human clinical trials.